• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性疟原虫裂殖子表面抗原 PfRH5 可诱导人类产生可检测水平的入侵抑制抗体。

Plasmodium falciparum merozoite surface antigen, PfRH5, elicits detectable levels of invasion-inhibiting antibodies in humans.

机构信息

Harvard School of Public Health.

出版信息

J Infect Dis. 2013 Nov 15;208(10):1679-87. doi: 10.1093/infdis/jit385. Epub 2013 Jul 31.

DOI:10.1093/infdis/jit385
PMID:23904294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3805239/
Abstract

Plasmodium falciparum is an intracellular protozoan parasite that infects erythrocytes and hepatocytes. The blood stage of its life cycle causes substantial morbidity and mortality associated with millions of infections each year, motivating an intensive search for potential components of a multi-subunit vaccine. In this study, we present data showing that antibodies from natural infections can recognize a recombinant form of the relatively conserved merozoite surface antigen, PfRH5. Furthermore, we performed invasion inhibition assays on clinical isolates and laboratory strains of P. falciparum in the presence of affinity purified antibodies to RH5 and show that these antibodies can inhibit invasion in vitro.

摘要

疟原虫是一种感染红细胞和肝细胞的胞内原生动物寄生虫。其生命周期的血液阶段会导致大量的发病率和死亡率,每年与数百万感染相关,这促使人们积极寻找多亚基疫苗的潜在成分。在这项研究中,我们提供的数据表明,来自自然感染的抗体可以识别相对保守的裂殖子表面抗原 PfRH5 的重组形式。此外,我们在 RH5 的亲和纯化抗体存在下对临床分离株和实验室株的疟原虫进行了入侵抑制测定,结果表明这些抗体可以在体外抑制入侵。

相似文献

1
Plasmodium falciparum merozoite surface antigen, PfRH5, elicits detectable levels of invasion-inhibiting antibodies in humans.恶性疟原虫裂殖子表面抗原 PfRH5 可诱导人类产生可检测水平的入侵抑制抗体。
J Infect Dis. 2013 Nov 15;208(10):1679-87. doi: 10.1093/infdis/jit385. Epub 2013 Jul 31.
2
Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens.增强对恶性疟原虫红细胞入侵的阻断作用:评估 PfRH5 抗体与其他裂殖子抗原抗体联合应用的效果。
PLoS Pathog. 2012;8(11):e1002991. doi: 10.1371/journal.ppat.1002991. Epub 2012 Nov 8.
3
Bacterially expressed full-length recombinant Plasmodium falciparum RH5 protein binds erythrocytes and elicits potent strain-transcending parasite-neutralizing antibodies.细菌表达全长重组恶性疟原虫 RH5 蛋白与红细胞结合,并引发强效的跨株寄生虫中和抗体。
Infect Immun. 2014 Jan;82(1):152-64. doi: 10.1128/IAI.00970-13. Epub 2013 Oct 14.
4
Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate.恶性疟原虫网织红细胞结合蛋白同源物5相互作用蛋白PfRipr的鉴定,作为一种高度保守的血液期疟疾疫苗候选物。
Vaccine. 2016 Nov 4;34(46):5612-5622. doi: 10.1016/j.vaccine.2016.09.028. Epub 2016 Sep 28.
5
Antibodies against a Plasmodium falciparum RON12 inhibit merozoite invasion into erythrocytes.针对恶性疟原虫RON12的抗体可抑制裂殖子侵入红细胞。
Parasitol Int. 2019 Feb;68(1):87-91. doi: 10.1016/j.parint.2018.10.006. Epub 2018 Oct 17.
6
Identification of a potent combination of key Plasmodium falciparum merozoite antigens that elicit strain-transcending parasite-neutralizing antibodies.鉴定强效组合的关键恶性疟原虫裂殖子抗原,诱导跨越虫株的寄生虫中和抗体。
Infect Immun. 2013 Feb;81(2):441-51. doi: 10.1128/IAI.01107-12. Epub 2012 Nov 26.
7
Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.疟疾原虫裂殖子表面蛋白 4 型抗体与临床疟疾防护的相关性。
Vaccine. 2017 Dec 4;35(48 Pt B):6720-6726. doi: 10.1016/j.vaccine.2017.10.012. Epub 2017 Oct 15.
8
Functional Comparison of Blood-Stage Malaria Vaccine Candidate Antigens.血期疟疾疫苗候选抗原的功能比较。
Front Immunol. 2019 Jun 4;10:1254. doi: 10.3389/fimmu.2019.01254. eCollection 2019.
9
Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.恶性疟原虫的裂殖子表面蛋白1是获得性疟疾免疫个体中调理抗体的主要靶点。
Clin Vaccine Immunol. 2017 Nov 6;24(11). doi: 10.1128/CVI.00155-17. Print 2017 Nov.
10
A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein.一种基于恶性疟原虫RH5蛋白表位的疟疾候选疫苗。
Malar J. 2014 Aug 18;13:326. doi: 10.1186/1475-2875-13-326.

引用本文的文献

1
Erythrocyte invasion in malaria: from molecular mechanisms to rational vaccines.疟疾中的红细胞入侵:从分子机制到合理疫苗
Nat Rev Microbiol. 2025 Sep 15. doi: 10.1038/s41579-025-01235-1.
2
reticulocyte-binding homologues are targets of human inhibitory antibodies and play a role in immune evasion.网织红细胞结合同源物是人类抑制性抗体的靶标,并在免疫逃避中起作用。
Front Immunol. 2025 Mar 25;16:1532451. doi: 10.3389/fimmu.2025.1532451. eCollection 2025.
3
Vaccine-induced human monoclonal antibodies to PfRH5 show broadly neutralizing activity against P. falciparum clinical isolates.疫苗诱导产生的针对恶性疟原虫红细胞结合抗原5(PfRH5)的人源单克隆抗体对恶性疟原虫临床分离株具有广泛的中和活性。
NPJ Vaccines. 2024 Oct 24;9(1):198. doi: 10.1038/s41541-024-00986-x.
4
Persistence of Anti-SE36 Antibodies Induced by the Malaria Vaccine Candidate BK-SE36/CpG in 5-10-Year-Old Burkinabe Children Naturally Exposed to Malaria.疟疾候选疫苗BK-SE36/CpG诱导的抗SE36抗体在自然暴露于疟疾的5至10岁布基纳法索儿童体内的持久性。
Vaccines (Basel). 2024 Feb 6;12(2):166. doi: 10.3390/vaccines12020166.
5
The Need for Novel Asexual Blood-Stage Malaria Vaccine Candidates for .新型无性血期疟疾疫苗候选物的需求。
Biomolecules. 2024 Jan 12;14(1):100. doi: 10.3390/biom14010100.
6
High genetic and haplotype diversity in vaccine candidate but not among malaria-infected children in Ibadan, Nigeria.在尼日利亚伊巴丹,候选疫苗具有高遗传和单倍型多样性,但疟疾感染儿童中没有。
PeerJ. 2023 Dec 11;11:e16519. doi: 10.7717/peerj.16519. eCollection 2023.
7
A novel asexual blood-stage malaria vaccine candidate: PfRipr5 formulated with human-use adjuvants induces potent growth inhibitory antibodies.一种新型的无性血阶段疟疾疫苗候选物:与人类使用佐剂联合配制的 PfRipr5 可诱导出强大的生长抑制抗体。
Front Immunol. 2022 Oct 27;13:1002430. doi: 10.3389/fimmu.2022.1002430. eCollection 2022.
8
Structure-guided insights into potential function of novel genetic variants in the malaria vaccine candidate PfRh5.结构导向洞察疟疾疫苗候选蛋白 PfRh5 新型遗传变异的潜在功能
Sci Rep. 2022 Nov 12;12(1):19403. doi: 10.1038/s41598-022-23929-9.
9
Asexual Blood-Stage Malaria Vaccine Candidate PfRipr5: Enhanced Production in Insect Cells.无性血液期疟疾疫苗候选物PfRipr5:在昆虫细胞中的产量提高
Front Bioeng Biotechnol. 2022 Jun 30;10:908509. doi: 10.3389/fbioe.2022.908509. eCollection 2022.
10
Scalable Process for High-Yield Production of CyRPA Using Insect Cells for Inclusion in a Malaria Virosome-Based Vaccine Candidate.利用昆虫细胞高产生产CyRPA的可扩展工艺,用于纳入基于疟疾病毒体的候选疫苗。
Front Bioeng Biotechnol. 2022 May 20;10:879078. doi: 10.3389/fbioe.2022.879078. eCollection 2022.

本文引用的文献

1
A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants.全长重组恶性疟原虫 PfRH5 蛋白诱导具有抑制活性的抗体,可有效针对常见 PfRH5 遗传变异体。
Vaccine. 2013 Jan 2;31(2):373-9. doi: 10.1016/j.vaccine.2012.10.106. Epub 2012 Nov 10.
2
Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens.增强对恶性疟原虫红细胞入侵的阻断作用:评估 PfRH5 抗体与其他裂殖子抗原抗体联合应用的效果。
PLoS Pathog. 2012;8(11):e1002991. doi: 10.1371/journal.ppat.1002991. Epub 2012 Nov 8.
3
The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody.疟原虫血期抗原 PfRH5 易受疫苗诱导的交叉株中和抗体的影响。
Nat Commun. 2011 Dec 20;2:601. doi: 10.1038/ncomms1615.
4
What is the efficacy of the RTS,S malaria vaccine?RTS,S疟疾疫苗的疗效如何?
BMJ. 2011 Dec 13;343:d7728. doi: 10.1136/bmj.d7728.
5
Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum.Basigin 是恶性疟原虫入侵红细胞所必需的受体。
Nature. 2011 Nov 9;480(7378):534-7. doi: 10.1038/nature10606.
6
An EGF-like protein forms a complex with PfRh5 and is required for invasion of human erythrocytes by Plasmodium falciparum.一种表皮生长因子样蛋白与 PfRh5 形成复合物,对于恶性疟原虫入侵人红细胞是必需的。
PLoS Pathog. 2011 Sep;7(9):e1002199. doi: 10.1371/journal.ppat.1002199. Epub 2011 Sep 1.
7
Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial.RTS,S/AS01E 候选疟疾疫苗与扩大免疫规划疫苗联合接种的安全性和有效性:一项随机、开放标签、2 期临床试验的 19 个月随访。
Lancet Infect Dis. 2011 Oct;11(10):741-9. doi: 10.1016/S1473-3099(11)70100-1. Epub 2011 Jul 22.
8
Host cell invasion by apicomplexan parasites: insights from the co-structure of AMA1 with a RON2 peptide.顶复门寄生虫对宿主细胞的入侵:来自 AMA1 与 RON2 肽共结构的新见解。
Science. 2011 Jul 22;333(6041):463-7. doi: 10.1126/science.1204988.
9
Plasmodium falciparum reticulocyte binding-like homologue protein 2 (PfRH2) is a key adhesive molecule involved in erythrocyte invasion.恶性疟原虫红细胞结合样同源蛋白 2(PfRH2)是一种参与红细胞入侵的关键黏附分子。
PLoS One. 2011 Feb 28;6(2):e17102. doi: 10.1371/journal.pone.0017102.
10
Reticulocyte and erythrocyte binding-like proteins function cooperatively in invasion of human erythrocytes by malaria parasites.网状细胞和红细胞结合样蛋白在疟原虫入侵人红细胞中协同发挥作用。
Infect Immun. 2011 Mar;79(3):1107-17. doi: 10.1128/IAI.01021-10. Epub 2010 Dec 13.